Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Le informazioni sui progetti di Orizzonte 2020 e ora anche le relative sintesi delle relazioni sono disponibili su CORDIS. Tutti i progetti H2020 possono essere scaricati dal Portale Open Data dell'UE .

My refinements


Download results of this page


Perfeziona per:

Tipo di contenuto

Progetto (1008)
Risultato in breve (4846)
Sintesi della relazione (1467)

Paese

Albania (7)
Algeria (2)
Argentina (11)
Armenia (2)
Australia (45)
Austria (260)
Bangladesh (5)
Belgio (439)
Benin (5)
Bielorussia (3)
Bolivia (3)
Bosnia-Erzegovina (3)
Botswana (2)
Brasile (21)
Bulgaria (24)
Burkina Faso (12)
Cambogia (2)
Camerun (7)
Canada (33)
Cile (5)
Cina (18)
Cipro (11)
Colombia (10)
Corea del Sud (6)
Costa Rica (2)
Croazia (23)
Cuba (2)
Danimarca (250)
Ecuador (3)
Egitto (7)
El Salvador (1)
Emirati arabi uniti (1)
Estonia (54)
Etiopia (5)
Ex Repubblica iugoslava di Macedonia (5)
Filippine (3)
Finlandia (190)
Francia (803)
Gabon (3)
Gambia (1)
Georgia (4)
Germania (1107)
Ghana (17)
Giappone (8)
Giordania (1)
Grecia (137)
Guatemala (2)
Guinea-Bissau (1)
Haiti (1)
Hong Kong (3)
India (34)
Indonesia (7)
Iran (1)
Irlanda (184)
Islanda (31)
Isole Vergini britanniche (1)
Israele (129)
Italia (670)
Kazakstan (3)
Kenya (14)
Lettonia (17)
Libano (1)
Lituania (24)
Lussemburgo (17)
Malawi (8)
Malaysia (3)
Mali (6)
Malta (4)
Marocco (6)
Maurizio (1)
Messico (8)
Moldova (5)
Mozambico (6)
Namibia (1)
Nepal (3)
Nicaragua (1)
Niger (1)
Nigeria (9)
Norvegia (115)
Nuova Zelanda (6)
Oman (1)
Paesi Bassi (806)
Pakistan (2)
Palestina (2)
Papua Nuova Guinea (1)
Perú (5)
Polinesia francese (1)
Polonia (107)
Portogallo (74)
Regno Unito (1159)
Repubblica ceca (79)
Repubblica centrafricana (1)
Repubblica democratica del Congo (2)
Romania (48)
Russia (24)
Senegal (5)
Serbia (8)
Singapore (5)
Siria (2)
Slovacchia (18)
Slovenia (49)
Spagna (507)
Sri Lanka (2)
Stati Uniti (127)
Sud Africa (31)
Sudan (6)
Svezia (459)
Svizzera (385)
Taiwan (4)
Tanzania (19)
Thailandia (7)
Togo (1)
Tunisia (10)
Turchia (32)
Ucraina (8)
Uganda (16)
Ungheria (103)
Uruguay (4)
Uzbekistan (2)
Venezuela (2)
Vietnam (8)
Zambia (3)

Advanced search

Cerca progetti e risultati

Results 1 - 10 of 7321
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Paediatric European Risperidone Studies
ID: 241959
Data di inizio: 2010-05-01, Termine: 2015-04-30
"Second-generation antipsychotics are increasingly being prescribed to children and adolescents. Their use, however, is mostly off-label, and adequate and sufficient data about efficacy and particular safety are lacking. This proposal focuses on two indications, the use of ri...
Programme: FP7-HEALTH
Record Number: 95491
Last updated on: 2015-03-10
Final Report Summary - PERS (Paediatric European Risperidone Studies)
The last decade showed a strong prescription rise and extensive off-label use of atypical antipsychotics (in particular risperidone) in children and adolescents with various psychiatric disorders. However, a serious lack of information on efficacy and safety of these...
Programme: FP7-HEALTH
Record Number: 191752
Last updated on: 2016-11-11
Final Report Summary - ASSET (ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours)
Executive Summary ASSET applied a systems level approach to study embryonal tumours (ET), which include neuroblastoma (NB), medulloblastoma (MB) and Ewing sarcoma family tumours (ESFT). These tumours arise in babies and children, and are devastating for the patients and their...
Programme: FP7-HEALTH
Record Number: 191744
Last updated on: 2016-11-11
ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours
ID: 259348
Data di inizio: 2010-11-01, Termine: 2016-04-30
Cancer is hallmarked by multiple genetic aberrations that lead to a functional derangement of cellular signalling networks. Embryonal tumours (ETs) comprising neuroblastoma, medulloblastoma and Ewing sarcoma, occur early in life, and thus may reveal pathogenetically relevant ...
Programme: FP7-HEALTH
Record Number: 97171
Last updated on: 2016-04-11
Persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes - an innovative research program of biobanks and expertise
ID: 261441
Data di inizio: 2011-01-01, Termine: 2016-06-30
"Type 1 diabetes is caused by an inflammatory process which damage insulin-producing beta-cells in the pancreas. It is one of the most common chronic diseases and its incidence is rapidly increasing. Due to its complications it causes a significant medical and economic burden...
Programme: FP7-HEALTH
Record Number: 97704
Last updated on: 2015-06-29
Final Report Summary - PEVNET (Persistent virus infection as a cause of pathogenic inflammation in type 1 diabetes - an innovative research program of biobanks and expertise)
PEVNET programme aims at providing a rational basis for the development of therapies based on one of the most promising pathogen-disease associations, namely the association between enteroviruses and type 1 diabetes. A causal association between enterovirus and type 1 diabetes...
Programme: FP7-HEALTH
Record Number: 191674
Last updated on: 2016-11-11
Metformin for treatment of polycystic ovary syndrome in children
ID: 602243
Data di inizio: 2013-10-01, Termine: 2017-03-31
PCOS, a common disorder affecting 5-10% of women of reproductive age is characterized by cystic ovarian morphology, androgen excess, and/or irregular periods and emerges during or shortly after puberty. The common off-label use of metformin for treating PCOS in children appea...
Programme: FP7-HEALTH
Record Number: 110171
Last updated on: 2017-01-30
Final Report Summary - METFIZZ (Metformin for treatment of polycystic ovary syndrome in children)
On January 13, 2012, EMA released an updated priority list (“call”) for requested Paediatric Use Marketing Authorization (PUMA) studies into off-patent medicinal products (EMA Reflection paper: formulations of choice for the paediatric population (emea/chmp/...
Programme: FP7-HEALTH
Record Number: 191649
Last updated on: 2016-11-10
Diagnostic and prognostic biomarkers for inflammatory bowel disease
IBD-BIOM
ID: 305479
Data di inizio: 2012-10-01, Termine: 2016-09-30
Inflammatory bowel diseases affect 0.8% of the Europeans, and are associated with high morbidity, definite mortality and an increasing economic burden. Current diagnostic tools and therapeutics for IBD are unsatisfactory. Development of biomarkers allowing insights into patho...
Programme: FP7-HEALTH
Record Number: 105203
Last updated on: 2016-06-27
Un paso importante hacia el desarrollo de tratamientos personalizados para la EII
Investigadores de un proyecto financiado por la Unión Europea han realizado avances significativos en el desarrollo de nuevas herramientas para el diagnóstico y pronóstico de la enfermedad inflamatoria intestinal (EII) que podrían conducir al diseño de estrategias terapéuticas dirigidas y tratamientos personalizados más eficaces.
Programme: FP7-HEALTH
Record Number: 158576
Last updated on: 2017-02-24
Available languages: DE, EN, ES, FR, IT, PL
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-02-26